Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing animal and preliminary human studies without systematic methodology
OpenAlex W2118842889 · doi:10.3389/fphar.2012.00024
What was done
The author conducted a narrative review of existing scientific literature evaluating the potential of Moringa oleifera leaves to correct chronic hyperglycemia and dyslipidemia associated with diabetes and cardiovascular disease risk, covering both experimental animal and human studies.
What was found
The abstract provides no quantitative data or effect sizes. It reports that available studies in animals and humans, while limited in number and variable in study design, generally agree in supporting the corrective potential of Moringa oleifera leaves on hyperglycemia and dyslipidemia.
Why it matters
This review contrasts popular health claims with the early state of the evidence, clarifying that while preliminary biological rationale exists, therapeutic applications remain unproven.
Limits
The paper is a narrative review rather than a systematic review or meta-analysis. The underlying evidence base is characterized by small numbers of heterogeneous studies, mostly in animals, with unknown sample sizes and lacking established clinical dosing or safety data.
Cited by
- supports Moringa oleifera originated in Northern India near the border with Pakistan.